{ "article": { "LEGIARTI000030186932": { "META": { "META_SPEC": { "META_ARTICLE": { "NUM": "R5121-201-1", "ETAT": "ABROGE", "TYPE": "AUTONOME", "DATE_FIN": "2016-12-15", "DATE_DEBUT": "2015-02-04" } }, "META_COMMUN": { "ID": "LEGIARTI000030186932", "URL": "article/LEGI/ARTI/00/00/30/18/69/LEGIARTI000030186932.xml", "NATURE": "Article", "ORIGINE": "LEGI" } }, "LIENS": { "LIEN": [ { "@id": "LEGIARTI000030186608", "@num": "6", "#text": "DÉCRET n°2015-100 du 2 février 2015 - art. 6", "@sens": "cible", "@cidtexte": "JORFTEXT000030185960", "@nortexte": "AFSP1431045D", "@numtexte": "2015-100", "@typelien": "CREE", "@naturetexte": "DECRET", "@datesignatexte": "2015-02-02" }, { "@id": "LEGIARTI000033601880", "@num": "6", "#text": "Décret n°2016-1706 du 12 décembre 2016 - art. 6", "@sens": "cible", "@cidtexte": "JORFTEXT000033585836", "@nortexte": "AFSP1629709D", "@numtexte": "2016-1706", "@typelien": "ABROGE", "@naturetexte": "DECRET", "@datesignatexte": "2016-12-12" } ] }, "CONTEXTE": { "TEXTE": { "TM": { "TM": { "TM": { "TM": { "TM": { "TM": { "TM": { "TM": { "TITRE_TM": [ { "@id": "LEGISCTA000030186918", "@fin": "2016-12-15", "#text": "Paragraphe 4 : Médicaments définis au b du 18° de l'article L. 5121-1", "@debut": "2015-02-04" } ] }, "TITRE_TM": [ { "@id": "LEGISCTA000006196563", "@fin": "2999-01-01", "#text": "Sous-section 5 : Médicaments dérivés du sang", "@debut": "2004-08-08" } ] }, "TITRE_TM": [ { "@id": "LEGISCTA000006190672", "@fin": "2999-01-01", "#text": "Section 13 : Pharmacovigilance", "@debut": "2004-08-08" } ] }, "TITRE_TM": [ { "@id": "LEGISCTA000006178649", "@fin": "2999-01-01", "#text": "Chapitre Ier : Dispositions générales", "@debut": "2004-08-08" } ] }, "TITRE_TM": [ { "@id": "LEGISCTA000006161012", "@fin": "2999-01-01", "#text": "Titre II : Médicaments à usage humain", "@debut": "2004-08-08" } ] }, "TITRE_TM": [ { "@id": "LEGISCTA000006145489", "@fin": "2999-01-01", "#text": "Livre Ier : Produits pharmaceutiques", "@debut": "2004-07-29" } ] }, "TITRE_TM": [ { "@id": "LEGISCTA000006132399", "@fin": "2999-01-01", "#text": "Cinquième partie : Produits de santé", "@debut": "2004-07-29" } ] }, "TITRE_TM": [ { "@id": "LEGISCTA000006112927", "@fin": "2999-01-01", "#text": "Partie réglementaire", "@debut": "2000-12-23" } ] }, "@cid": "LEGITEXT000006072665", "@nature": "CODE", "TITRE_TXT": [ { "@fin": "2999-01-01", "#text": "Code de la santé publique", "@debut": "1953-10-07", "@id_txt": "LEGITEXT000006072665", "@c_titre_court": "Code de la santé publique" } ], "@date_publi": "2999-01-01", "@date_signature": "2999-01-01" } }, "VERSIONS": { "VERSION": [ { "@etat": "ABROGE", "LIEN_ART": { "@id": "LEGIARTI000030186932", "@fin": "2016-12-15", "@num": "R5121-201-1", "@etat": "ABROGE", "@debut": "2015-02-04", "@origine": "LEGI" } } ] }, "BLOC_TEXTUEL": { "CONTENU": "

Les médicaments dérivés du sang mentionnés au b du 18° de l'article L. 5121-1 sont délivrés et conservés en vue de leur délivrance par les établissements de transfusion sanguine ou les établissements de santé autorisés à cet effet dans les conditions précisées par la section 3 du chapitre Ier du titre II du livre II de la première partie du présent code.

" } }, "LEGIARTI000030186608": { "META": { "META_SPEC": { "META_ARTICLE": { "NUM": "6", "TYPE": "ENTIEREMENT_MODIF", "DATE_FIN": "2999-01-01", "DATE_DEBUT": "2999-01-01" } }, "META_COMMUN": { "ID": "LEGIARTI000030186608", "URL": "article/LEGI/ARTI/00/00/30/18/66/LEGIARTI000030186608.xml", "NATURE": "Article", "ORIGINE": "LEGI" } }, "LIENS": { "LIEN": [ { "@id": "LEGISCTA000030186918", "#text": "Code de la santé publique - Paragraphe 4 : Médicaments définis au b du 18° ... (Ab)", "@sens": "source", "@cidtexte": "LEGITEXT000006072665", "@typelien": "CREE", "@naturetexte": "CODE", "@datesignatexte": "2999-01-01" }, { "@id": "LEGIARTI000030186932", "@num": "R5121-201-1", "#text": "Code de la santé publique - art. R5121-201-1 (Ab)", "@sens": "source", "@cidtexte": "LEGITEXT000006072665", "@typelien": "CREE", "@naturetexte": "CODE", "@datesignatexte": "2999-01-01" }, { "@id": "LEGIARTI000030186942", "@num": "R5121-201-2", "#text": "Code de la santé publique - art. R5121-201-2 (Ab)", "@sens": "source", "@cidtexte": "LEGITEXT000006072665", "@typelien": "CREE", "@naturetexte": "CODE", "@datesignatexte": "2999-01-01" }, { "@id": "LEGIARTI000030187014", "@num": "R5121-201-3", "#text": "Code de la santé publique - art. R5121-201-3 (Ab)", "@sens": "source", "@cidtexte": "LEGITEXT000006072665", "@typelien": "CREE", "@naturetexte": "CODE", "@datesignatexte": "2999-01-01" }, { "@id": "LEGIARTI000030188760", "@num": "R5124-45", "#text": "Code de la santé publique - art. R5124-45 (V)", "@sens": "source", "@cidtexte": "LEGITEXT000006072665", "@typelien": "MODIFIE", "@naturetexte": "CODE", "@datesignatexte": "2999-01-01" }, { "@id": "LEGIARTI000030188729", "@num": "R5126-112", "#text": "Code de la santé publique - art. R5126-112 (M)", "@sens": "source", "@cidtexte": "LEGITEXT000006072665", "@typelien": "MODIFIE", "@naturetexte": "CODE", "@datesignatexte": "2999-01-01" }, { "@id": "LEGIARTI000030188751", "@num": "R5126-8", "#text": "Code de la santé publique - art. R5126-8 (M)", "@sens": "source", "@cidtexte": "LEGITEXT000006072665", "@typelien": "MODIFIE", "@naturetexte": "CODE", "@datesignatexte": "2999-01-01" }, { "@id": "LEGIARTI000030187184", "@num": "R5126-8-1", "#text": "Code de la santé publique - art. R5126-8-1 (M)", "@sens": "source", "@cidtexte": "LEGITEXT000006072665", "@typelien": "CREE", "@naturetexte": "CODE", "@datesignatexte": "2999-01-01" } ] }, "CONTEXTE": { "TEXTE": { "@cid": "JORFTEXT000030185960", "@nor": "AFSP1431045D", "@num": "2015-100", "@nature": "DECRET", "TITRE_TXT": [ { "@fin": "2999-01-01", "#text": "Décret n° 2015-100 du 2 février 2015 relatif au plasma dans la production duquel intervient un processus industriel", "@debut": "2999-01-01", "@id_txt": "JORFTEXT000030185960", "@c_titre_court": "DÉCRET n°2015-100 du 2 février 2015" }, { "@fin": "2999-01-01", "#text": "Décret n° 2015-100 du 2 février 2015 relatif au plasma dans la production duquel intervient un processus industriel", "@debut": "2015-02-04", "@id_txt": "LEGITEXT000030186598", "@c_titre_court": "DÉCRET n°2015-100 du 2 février 2015" } ], "@ministere": "Ministère des affaires sociales, de la santé et des droits des femmes", "@date_publi": "2015-02-03", "@date_signature": "2015-02-02" } }, "VERSIONS": { "VERSION": [ { "LIEN_ART": { "@id": "LEGIARTI000030186608", "@fin": "2999-01-01", "@num": "6", "@debut": "2999-01-01", "@origine": "LEGI" } }, { "LIEN_ART": { "@id": "JORFARTI000030185981", "@fin": "2999-01-01", "@num": "6", "@debut": "2999-01-01", "@origine": "JORF" } } ] }, "BLOC_TEXTUEL": { "CONTENU": "

\n
A modifié les dispositions suivantes :

-Code de la santé publique
\nSct. Paragraphe 4 : Médicaments définis au b du 18° de l'article L. 5121-1, Art. R5121-201-1, Art. R5121-201-2, Art. R5121-201-3, Art. R5124-45, Art. R5126-8, Art. R5126-8-1 \n
\n

A modifié les dispositions suivantes :

-Code de la santé publique
\nArt. R5126-112\n
\n

\n
" } }, "LEGIARTI000033601880": { "META": { "META_SPEC": { "META_ARTICLE": { "NUM": "6", "TYPE": "ENTIEREMENT_MODIF", "DATE_FIN": "2999-01-01", "DATE_DEBUT": "2999-01-01" } }, "META_COMMUN": { "ID": "LEGIARTI000033601880", "URL": "article/LEGI/ARTI/00/00/33/60/18/LEGIARTI000033601880.xml", "NATURE": "Article", "ORIGINE": "LEGI" } }, "LIENS": { "LIEN": [ { "@id": "LEGISCTA000030186918", "#text": "Code de la santé publique - Paragraphe 4 : Médicaments définis au b du 18° ... (Ab)", "@sens": "source", "@cidtexte": "LEGITEXT000006072665", "@typelien": "ABROGE", "@naturetexte": "CODE", "@datesignatexte": "2999-01-01" }, { "@id": "LEGIARTI000033606241", "@num": "R5121-187", "#text": "Code de la santé publique - art. R5121-187 (V)", "@sens": "source", "@cidtexte": "LEGITEXT000006072665", "@typelien": "MODIFIE", "@naturetexte": "CODE", "@datesignatexte": "2999-01-01" }, { "@id": "LEGIARTI000030186932", "@num": "R5121-201-1", "#text": "Code de la santé publique - art. R5121-201-1 (Ab)", "@sens": "source", "@cidtexte": "LEGITEXT000006072665", "@typelien": "ABROGE", "@naturetexte": "CODE", "@datesignatexte": "2999-01-01" }, { "@id": "LEGIARTI000030186942", "@num": "R5121-201-2", "#text": "Code de la santé publique - art. R5121-201-2 (Ab)", "@sens": "source", "@cidtexte": "LEGITEXT000006072665", "@typelien": "ABROGE", "@naturetexte": "CODE", "@datesignatexte": "2999-01-01" }, { "@id": "LEGIARTI000030187014", "@num": "R5121-201-3", "#text": "Code de la santé publique - art. R5121-201-3 (Ab)", "@sens": "source", "@cidtexte": "LEGITEXT000006072665", "@typelien": "ABROGE", "@naturetexte": "CODE", "@datesignatexte": "2999-01-01" }, { "@id": "LEGIARTI000033606189", "@num": "R5124-45", "#text": "Code de la santé publique - art. R5124-45 (M)", "@sens": "source", "@cidtexte": "LEGITEXT000006072665", "@typelien": "MODIFIE", "@naturetexte": "CODE", "@datesignatexte": "2999-01-01" }, { "@id": "LEGIARTI000033606165", "@num": "R5126-112", "#text": "Code de la santé publique - art. R5126-112 (M)", "@sens": "source", "@cidtexte": "LEGITEXT000006072665", "@typelien": "MODIFIE", "@naturetexte": "CODE", "@datesignatexte": "2999-01-01" }, { "@id": "LEGIARTI000033606160", "@num": "R5126-8", "#text": "Code de la santé publique - art. R5126-8 (M)", "@sens": "source", "@cidtexte": "LEGITEXT000006072665", "@typelien": "MODIFIE", "@naturetexte": "CODE", "@datesignatexte": "2999-01-01" }, { "@id": "LEGIARTI000033606186", "@num": "R5126-8-1", "#text": "Code de la santé publique - art. R5126-8-1 (Ab)", "@sens": "source", "@cidtexte": "LEGITEXT000006072665", "@typelien": "MODIFIE", "@naturetexte": "CODE", "@datesignatexte": "2999-01-01" } ] }, "CONTEXTE": { "TEXTE": { "@cid": "JORFTEXT000033585836", "@nor": "AFSP1629709D", "@num": "2016-1706", "@nature": "DECRET", "TITRE_TXT": [ { "@fin": "2999-01-01", "#text": "Décret n° 2016-1706 du 12 décembre 2016 relatif au plasma à finalité transfusionnelle dans la production duquel intervient un processus industriel", "@debut": "2999-01-01", "@id_txt": "JORFTEXT000033585836", "@c_titre_court": "Décret n°2016-1706 du 12 décembre 2016" }, { "@fin": "2999-01-01", "#text": "Décret n° 2016-1706 du 12 décembre 2016 relatif au plasma à finalité transfusionnelle dans la production duquel intervient un processus industriel", "@debut": "2016-12-15", "@id_txt": "LEGITEXT000033601872", "@c_titre_court": "Décret n°2016-1706 du 12 décembre 2016" } ], "@ministere": "Ministère des affaires sociales et de la santé", "@date_publi": "2016-12-14", "@date_signature": "2016-12-12", "@num_parution_jo": "0290" } }, "VERSIONS": { "VERSION": [ { "LIEN_ART": { "@id": "LEGIARTI000033601880", "@fin": "2999-01-01", "@num": "6", "@debut": "2999-01-01", "@origine": "LEGI" } }, { "LIEN_ART": { "@id": "JORFARTI000033585861", "@fin": "2999-01-01", "@num": "6", "@debut": "2999-01-01", "@origine": "JORF" } } ] }, "BLOC_TEXTUEL": { "CONTENU": "
\n
A abrogé les dispositions suivantes :

- Code de la santé publique
\n Sct. Paragraphe 4 : Médicaments définis au b du 18° de l'article L. 5121-1, Art. R5121-201-1, Art. R5121-201-2, Art. R5121-201-3\n
\n

\n
\n
A modifié les dispositions suivantes :

- Code de la santé publique
\n Art. R5121-187, Art. R5124-45, Art. R5126-8-1, Art. R5126-112, Art. R5126-8\n
\n

\n
" } } }, "article_lien": [ { "article_id": "LEGIARTI000033601880", "cible": false, "cidtexte": "LEGITEXT000006072665", "id": "LEGIARTI000030186932", "typelien": "ABROGE" }, { "article_id": "LEGIARTI000030186608", "cible": false, "cidtexte": "LEGITEXT000006072665", "id": "LEGIARTI000030186932", "typelien": "CREE" } ], "follow": [ "LIENS.LIEN[@sens=cible,@typelien=CREATION].@id" ], "id": "LEGIARTI000030186932", "liens_entrants": true }

Article R5121-201-1 AUTONOME ABROGE, en vigueur du 04/02/2015 au 15/12/2016 (Code de la santé publique)